Wednesday, May 20, 2026

Imperagen raises £5 million to use quantum physics, AI on enzyme engineering

Biotech company Imperagen announced on Thursday a £5 million ($6.7 million) seed round led by PXN Ventures, with participation from IQ Capital and Northern Gritstone.

Posted from: this blog via Microsoft Power Automate.

Share:

0 comments:

Post a Comment